Sopharma AD (SPH) — Capital Reinvestment Ratio
Latest as of December 2024:
1.72x
Sopharma AD (SPH) has a Capital Reinvestment Ratio of 1.72x as of December 2024, meaning it reinvests 2% of its operating cash flow (zł54.42 Million) in capital expenditures (zł93.50 Million). See SPH cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.72x
Capex / Operating Cash Flow
Operating Cash Flow
zł54.42 Million
PLN
Capital Expenditures
zł93.50 Million
PLN
Data as of
Dec 2024
Most recent filing
Sopharma AD Capital Reinvestment Ratio (2011–2024)
This chart tracks Sopharma AD's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Sopharma AD (2011–2024)
Year-by-year Capital Reinvestment Ratio for Sopharma AD from 2011 to 2024. For live market cap and broader valuation context, see Sopharma AD stock valuation.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.58x | zł76.73 Million | zł121.39 Million | ▲ +64.6% |
| 2023 | 0.96x | zł45.03 Million | zł43.29 Million | ▲ +415.9% |
| 2022 | 0.19x | zł124.62 Million | zł23.22 Million | ▼ -81.0% |
| 2018 | 0.98x | zł28.34 Million | zł27.84 Million | ▲ +74.4% |
| 2017 | 0.56x | zł40.00 Million | zł22.53 Million | ▲ +56.5% |
| 2016 | 0.36x | zł50.64 Million | zł18.23 Million | ▼ -66.0% |
| 2015 | 1.06x | zł21.31 Million | zł22.59 Million | ▼ -18.0% |
| 2014 | 1.29x | zł20.18 Million | zł26.07 Million | ▲ +2.3% |
| 2013 | 1.26x | zł29.25 Million | zł36.96 Million | ▼ -29.9% |
| 2012 | 1.80x | zł35.20 Million | zł63.43 Million | ▲ +69.0% |
| 2011 | 1.07x | zł38.40 Million | zł40.97 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow